Cytokinetics vs Foghorn Therapeutics
CYTK and FHTX side by side, both in drugs. Figures are trailing twelve months unless noted, from SEC filings and end-of-day prices.
How CYTK and FHTX compare
Foghorn Therapeutics is the larger company, worth 17 times as much as Cytokinetics ($109M against $6.4M).
Foghorn Therapeutics grew revenue faster over the last twelve months (52.0% versus −21.1% for Cytokinetics).
Foghorn Therapeutics keeps more of each dollar of sales as profit, with a net margin of −176% compared with −1321% at Cytokinetics.
Foghorn Therapeutics scores higher on the StockData Score (9 against 4 for Cytokinetics), which adds up 30 checks on valuation, growth, past performance, financial health and dividends.
Key numbers
A dot marks the better figure where higher or lower is clearly better.
| Metric | CYTK | FHTX |
|---|---|---|
| Size and price | ||
| Market cap | $6.4M | $109M |
| Share price | $51.65 | $1.83 |
| Change, 1 year | −22.3% | −61.0% |
| Change, 5 years | 32.3% | −86.6% |
| Beta (5Y) | 1.12 | 2.82 |
| Employees | 673 | 106 |
| StockData Score | ||
| Total score | 4 | 9 (better) |
| Valuation score | 1 | 1 |
| Growth score | 1 | 2 (better) |
| Performance score | 1 | 1 |
| Health score | 1 | 5 (better) |
| Dividend score | 0 | 0 |
| Valuation | ||
| P/S | 0.1× (better) | 3.0× |
| FCF yield | −9034% | −77.6% (better) |
| Growth | ||
| Revenue growth (TTM) | −21.1% | 52.0% (better) |
| Revenue growth, 5Y average | 9.5% | 135% (better) |
| Profitability | ||
| Operating margin | −1046% | −198% (better) |
| Net margin | −1321% | −176% (better) |
| FCF margin | −858% | −229% (better) |
| Financial health | ||
| Current ratio | 6.66 (better) | 3.36 |
| Altman Z-score | −3.37 (better) | −4.61 |
| Piotroski F-score | 2 | 2 |
| Dividends and buybacks | ||
| Shareholder yield | 0.00% | 0.00% |
| Ownership | ||
| Held by institutions | 115% | 75.6% |
| Held by insiders | 0.68% | 36.3% |
| Insider net buying, 12 months | −$51.5M | – |
| Short interest, % of float | 13.0% | 6.0% |
Go deeper
- CYTK stock overview
- CYTK income statement
- CYTK valuation and score
- FHTX stock overview
- FHTX income statement
- FHTX valuation and score
For information only, not investment advice. Check the source filings before relying on any figure.